New Zealand-based Ora Pharm has unveiled plant processing and export services aimed at supporting other medicinal cannabis cultivators operating throughout the country.
The company said the initiative would reduce barriers to entry and boost profitability for growers by cutting plant processing costs, simplifying the export process, maintaining strict quality control, and increasing overall efficiency.
Ora Pharm noted that approximately one-third of New Zealand's licensed cannabis cultivators have opted to work with the company to date.
CEO Zoe Reece said: "Our mission is to bolster the growth and sustainability of New Zealand's medicinal cannabis industry. By providing these specialised services, we allow cultivators to focus on their core competency – growing premium medicinal cannabis – while we handle the processing and export logistics.
"This cooperative approach not only cuts costs, but also enhances the overall quality and reliability of New Zealand's medicinal cannabis in the global market."
New Zealand Medicinal Cannabis Council executive director Sally King added: "New Zealand's approach to this sunrise sector is to work collaboratively, supporting all participants – craft cultivators to vertically integrated suppliers – to expand NZ's reputation for sustainable, ethical, highest-quality medicinal cannabis genetics, ingredients and medicines.
"Ora Pharm's new export service is another significant step to growing New Zealand's share of premium, patient-focused medicinal cannabis solutions for the world. An important and very welcome development."
In a separate development, Ora Pharm said Breathe Life Sciences has selected it as the sole New Zealand supplier on its AI-generated cannabis trading platform CanXChange, citing the company's capacity to represent products from multiple cultivators.
The invite-only B2B platform is designed to allow pharmacies, licensed manufacturers, and cultivators to conduct transactions in a secure and accessible environment.
Ora Pharm said the exclusive supply agreement would unlock what it described as "significant opportunities" for New Zealand products to enter the Australian market.
